Company Filing History:
2 out of 181 
1 out of 621 
1 out of 1,719 
Years Active: 2011-2017
Title: **Wenya Huang: Pioneering Innovations in Hepatitis B Research**
Introduction
Wenya Huang is a distinguished inventor based in Tainan, Taiwan, recognized for his significant contributions to the field of hepatitis B research. With a total of three patents to his name, he has developed innovative methods and tools that enhance the detection and understanding of hepatitis B virus (HBV) variants, particularly relating to their implications for liver disease.
Latest Patents
Wenya Huang's latest patents encompass essential advancements in the detection of pre-Sdeletion mutant LHBS, which is crucial for managing chronic HBV carriers and patients post-hepatectomy. His patents involve the development of a specific HBS antibody, a LHBS-specific antibody, and a WT LHBS-specific antibody. The immunoassay kit he has designed includes a method for detecting pre-Sdeletion mutant LHBS using these antibodies. This method enables the calculation of the pre-Sdeletion mutant LHBS protein in biological samples while minimizing the potential mutual influence of WT LHBS, significantly streamlining the analysis process. Additionally, Huang has innovated combinations of novel oligonucleotides for detecting deletions in the Pre-S region of HBV, which is linked to an elevated risk of conditions such as cirrhosis and hepatocellular carcinoma.
Career Highlights
Throughout his career, Huang has been associated with esteemed organizations such as the National Health Research Institutes and National Cheng Kung University. His tenure at these institutions has been marked by a commitment to advancing scientific knowledge and public health, particularly in the realm of viral hepatitis.
Collaborations
Wenya Huang has collaborated with notable individuals such as Ih-Jen Su and Woei-Jer Chuang, both of whom have played a role in his research endeavors. These collaborations have fostered a rich environment for innovation and development, further driving the research that underpins his patented technologies.
Conclusion
With his innovative patents and collaborative spirit, Wenya Huang continues to make impactful strides in hepatitis B research. His work not only advances scientific understanding but also provides vital tools for the early detection and management of liver disease, ultimately contributing to better health outcomes for patients worldwide.